1993
DOI: 10.1083/jcb.122.3.685
|View full text |Cite
|
Sign up to set email alerts
|

Osteoblasts are target cells for transformation in c-fos transgenic mice

Abstract: Abstract. We have generated transgenic mice expressing the proto-oncogene c-fos from an H-2K b class I MHC promoter as a tool to identify and isolate cell populations which are sensitive to altered levels of Fos

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
245
3
5

Year Published

1997
1997
2004
2004

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 319 publications
(256 citation statements)
references
References 93 publications
3
245
3
5
Order By: Relevance
“…In contrast to these ®ndings, transgenic mice carrying either the H2-fosBLTR or the H2-cjunLTR construct did not develop any phenotypic abnormalities or tumours, despite high level expression of the transgene in a broad range of tissues (Grigoriadis et al, 1993). Given existing knowledge of these AP-1 family members, these results may have been unexpected.…”
Section: Discussioncontrasting
confidence: 63%
See 1 more Smart Citation
“…In contrast to these ®ndings, transgenic mice carrying either the H2-fosBLTR or the H2-cjunLTR construct did not develop any phenotypic abnormalities or tumours, despite high level expression of the transgene in a broad range of tissues (Grigoriadis et al, 1993). Given existing knowledge of these AP-1 family members, these results may have been unexpected.…”
Section: Discussioncontrasting
confidence: 63%
“…In the case of c-fos, over-expression of the gene under the control of either the metallothionein (MT) promoter (Ruther et al, 1987) or the H2-K b promoter (Grigoriadis et al, 1993), combined with replacement of 3' UTR mRNAdestabilising sequences with a viral long terminal repeat (LTR) sequence, resulted in development of lesions on the long bones of the legs. The further development of these lesions into osteosarcomas was variable and may have depended upon the level of expression of the transgene.…”
Section: Discussionmentioning
confidence: 99%
“…The transcriptional regulation of fra-1 is unique among members of the fos gene family, since only fra-1 is subject to positive control by AP-1 activity (BruÈ sselbach et al, 1995;Bergers et al, 1995). The fra-1 gene is induced by ectopic expression of several members of the AP-1 family (c-Fos, v-Fos, FosB, Fra-1 and c-Jun) in several cell types (Bergers et al, 1995;Grigoriadis et al, 1993). Interestingly, the basal and AP-1 induced expression of fra-1 depends on regulatory sequences not only in the promoter region, but primarily in the ®rst intron which comprises a consensus AP-1 site and two TRE-like elements which di er by one nucleotide from the consensus AP-1 binding sequence (Bergers et al, 1995).…”
Section: Introductionmentioning
confidence: 99%
“…Since c-Fos is linked to osteosarcoma development from osteoblasts (Ruther et al, 1989;Grigoriadis et al, 1993), we first investigated if the tumor promoter sodium arsenite, hereafter referred to as As 3+ , activated c-fos expression in HOS cells. As 3+ treatment led to a robust induction of c-fos mRNA, albeit more slowly than epidermal growth factor (EGF) (Figure 1b).…”
Section: Arsenite Strongly Induces Ieg Transcription In Hos Cellsmentioning
confidence: 99%